Worldwide, more than 55 million people suffer from dementia caused by Alzheimer's Disease (AD) and other conditions that destroy cells in the brain and nervous system. While there is no treatment to ...

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative ...

NEW YORK, May 15, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem ...

ERNA-101 remains on track for IND-enabling studies in 2025, with first-in-human studies targeted for 2026.

BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on ...

Ovarian cancer remains the leading cause of death among cancers affecting the female reproductive system, largely because ...

BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative ...

Detailed price information for Biorestorative Therapies Inc (BRTX-Q) from The Globe and Mail including charting and trades.

The evolution of mesenchymal stem cell (MSC) therapy for cardiac disease. MSCs will play the central role in combination therapies supporting and orchestrating different cell types. Cytokines may also ...

But the retractions of the Alzheimer's paper on June 24, and the stem cell paper on ... found a molecular target that appeared influential in the onset of Alzheimer's disease, which remains ...

But the retractions of the Alzheimer’s paper on Monday and the stem cell paper ... found a molecular target that appeared influential in the onset of Alzheimer’s disease, which remains ...